SOPHiA GENETICS SA (SOPH): A Bull Case Theory [Yahoo! Finance]
SOPHiA GENETICS SA - Ordinary Shares (SOPH)
Company Research
Source: Yahoo! Finance
SOPHiA GENETICS SA (SOPH)'s share was trading at $3.64 as of Nov 1 st A clinical medical professional helping a patient while using an integrated health information technology software. Sophia Genetics is carving out a unique niche in the crowded cancer screening market, distinguishing itself from competitors like Grail, Guardant, and Natera by providing a sophisticated software platform, SOPHiA DDM, for analyzing sequencing results rather than performing the sequencing itself. This approach targets institutions that maintain in-house sequencing capabilities, allowing Sophia to leverage its machine learning and artificial intelligence technologies to enhance the analysis of data from various modalities, including next-generation sequencing (NGS), radiomics, and digital pathology. By serving primarily institutional customers, Sophia benefits from lower churn rates compared to firms focused on individual physicians, and it has the flexibility to expand its offerings beyond oncology,
Show less
Read more
Impact Snapshot
Event Time:
SOPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOPH alerts
High impacting SOPHiA GENETICS SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SOPH
News
- SOPHiA GENETICS SA (NASDAQ: SOPH) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $11.00 price target on the stock.MarketBeat
- SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024 [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024PR Newswire
- SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024PR Newswire
- SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024PR Newswire
SOPH
Earnings
- 11/5/24 - Miss
SOPH
Sec Filings
- 12/19/24 - Form 144
- 12/19/24 - Form 144
- 12/13/24 - Form 144
- SOPH's page on the SEC website